Engineering oncolytic bacteria as precision cancer therapeutics: Design principles, therapeutic strategies, and translational perspectives
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Jun-2026 23:17 ET (11-Jun-2026 03:17 GMT/UTC)
Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic delivery. This review summarizes recent advances in the design and application of synthetic biological strategies that enhance bacterial precision, safety, and efficacy in tumor therapy. These strategies are categorized into three major regulatory modes: exogenous input–responsive gene circuits, autonomous bacterial signal–responsive gene circuits, and tumor microenvironment-responsive gene circuits.
WASHINGTON, D.C. – U.S. Naval Research Laboratory (NRL) Engineer Shannon McGarry, Ph.D., received the Department of the Navy (DON) 2025 G. Dennis White Early Career Human Systems Integration (HSI) Practitioner Award for contributions and unwavering commitment embodying the essential qualities critical to the advancement of the HSI discipline, ensuring the safety and effectiveness of systems delivered to our warfighters.
Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers who created a Retrieval-Augmented Generation (RAG)–based AI tool that greatly outperforms manual review in assessing patient eligibility for clinical trial enrollment. The tool, called RECTIFIER, analyzes data from electronic health records—including visit notes and clinical reports—and has the potential to expand patient access to trials and accelerate drug discovery.
This study explores the role of methoxy polyethylene glycol@Elabela-11 (mPEG@ELA-11), a pH-responsive ELA-11 conjugate, in modulating macrophage function and attenuating atherosclerosis, focusing on the protein kinase B (AKT)-mediated endoplasmic reticulum (ER) stress pathway as a molecular target.
CSHL postdoc Miguel Santo Domingo Martinez and colleagues in the Lippman lab have used CRISPR gene editing to produce more compact goldenberry crops, making them easier to grow and harvest. The development could help bring this tasty fruit to farms and grocery stores around the globe.
Alcohol use disorder and risky alcohol drinking habits are important for primary care providers to know about and address with patients; a new study shows natural language processing, a form of artificial intelligence, could help.